Group Therapy Proposal for Parkinson's Patients
DOI:
https://doi.org/10.1921/gpwk20242260Keywords:
Parkinson's disease, Neuromuscular disorders, primary and secondary psychological symptoms in patientsAbstract
Parkinson’s Disease (PD) is a common, chronic, and progressive neurological condition that is associated with the loss of dopamine-producing cells deep in the brain. Every year, over 60,000 Americans are diagnosed with Parkinson’s and over six million people worldwide are living with the disease (Girouz & Farris, 2019). Parkinson’s is classified as a movement disorder because the most recognized symptoms are movement related; however, psychological symptoms are also associated Parkinson’s. The primary psychological symptoms are depression, and anxiety. This group proposal is designed to address primary and secondary psychological symptoms in patients diagnosed with Parkinson’s disease, or any other neuromuscular disorder.
References
Ambrosio, L., Portillo, M. C., Rodriguez, B. C., Rojo, J. M. & Martinez, M. P. (2019) Influencing factors when living with Parkinson’s disease: A cross-sectional study. Journal of Clinical Nursing, 28, 17–18, 3168–3176.
American Group Psychotherapy Association. (2002) AGPA and IBCGP guidelines for ethics.[Accessed January 26, 2020 at http://ethics.iit.edu/codes/AGPA%202002.pdf]
American Psychological Association. (2007) Guidelines for psychological practice with older adults.[[ Accessed (Date? ) at https://www.apa.org/pubs/journals/features/older-adults.pdf.]
Beck, A. T. (1979)Cognitive Therapy of Depression. New York: Guilford Press.
Berardelli, I., Belvisi, D., Pasquini, M., Fabbrini, A., Petrini, F., & Fabbrini, G. (2019)Treatment of psychiatric disturbances in hypokinetic movement disorders. Expert Review of Neurotherapeutics, 19, 10, 965–981
Corey, G., Corey, M.S. & Callanan, P. (1993) Issues and ethics in the helping professions. 4th ed. Belmont, CA: Thomson Brooks/Cole Publishing
Dobkin, R. D., Mann, S. L., Interian, A., Gara, M. A., & Menza, M. (2019).Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson’s disease. International Journal of Geriatric Psychiatry. 34, 5, 722-729. https://doi.org/10.1002/gps.5077
Dobkin, R. D., Tröster, A. I., Rubino, J. T., Allen, L. A., Gara, M. A., Mark, M. H., & Menza, M. (2014)Neuropsychological outcomes after psychosocial intervention for depression in Parkinson’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 26, 1, 57–63
Egan, S., Ladlaw, K., &Starkstein, S. (2015)Cognitive Behavior Therapy for Depression and Anxiety in Parkinson’s Disease. Journal of Parkinson’s Disease,5, 3, , 443-451
Farabaugh, A., Locascio, J. J., Yap, L., Growdon, J., Fava, M., Crawford, C., Matthews, J., McCutchen, J., Buchin, J., Pava, J. & Alpert, J. E. (2010) Cognitive–behavioral therapy for patients with Parkinson’s disease and comorbid major depressive disorder. Psychosomatics. Journal of Consultation and Liaison Psychiatry, 51, 2, 124–129
Folkman, S., & Greer, S. (2000) Promoting Psychological Well-Being in the Face of Serious Illness: When Theory, Research and Practice Inform Each Other. Psycho-Oncology, 9, 11-19.
Giroux, M. & Farris, S. (2016) Every Victory Counts. Essential Information and Inspiration for a Lifetime of Wellness with Parkinson’s Disease. Boston, MA: The Davis Phinney Foundation for Parkinsons.
Hadinia, A., Meyer, A., Bruegger, V., Hatz, F., Nowak, K., Taub, E., Nyberg, E., Stieglitz, R.-D., Fuhr, P. & Gschwandtner, U. (2017) Cognitive behavioral group therapy reduces stress and improves the quality of life in patients with Parkinson’s disease. Frontiers in Psychology, 7. psyh. https://doi.org/10.3389/fpsyg.2016.01975
Hofmann, S.G., Asnaani, A., Vonk, I., Sawyer, A. &Fang, A. (2012) The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognitive Therapy and Research, 36-427-440.
Karel, M. J. (2011) Ethics. in V. Molinari (Ed.) Specialty competencies in geropsychology. New York: Oxford University Press. (pp. 115–142)
Khan, A. U., Akram, M., Daniyal, M. & Zainab, R. (2019) Awareness and current knowledge of Parkinson’s disease: A neurodegenerative disorder. International Journal of Neuroscience, 129,1, 55-93
Martinez-Martin, P. (2011) The importance of non-motor disturbances to quality of life in Parkinson’s disease. Journal of the Neurological Sciences, 310, 1–2, 12–16.
McDermut, W., Miller, I. W., & Brown, R. A. (2001) The efficacy of group psychotherapy for depression: A meta-analysis and review of the empirical research. Clinical Psychology: Science and Practice, 8, 1, 98–116
Mohr, D., Classen, C. & Barrera, M. (2004)The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychological Medicine.34, 533-541
Substance Abuse and Mental Health Services Administration (2011) The treatment of depression in older adults: practitioner’s guide for working with older adults and depression [Accessed January 18, 2020 at https://store.samhsa.gov/product/Treatment-of-Depression-in-Older-Adults-Evidence-Based-Practices-EBP-KIT/SMA11-4631]
Troeung, L., Egan, S. J.& Gasson, N. (2014).A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease. BMC Psychiatry, 14. more citation?
Weintraub, D. & Mamikonyan, E. (2019) The neuropsychiatry of parkinson disease: A perfect storm. The American Journal of Geriatric Psychiatry. psyh. https://doi.org/10.1016/j.jagp.2019.03.002 Is this an obnline soutce – needs more citation
Yalom, I., (2005) The Theory and Practice of Group Psychotherapy. Cambridge, MA. Basic Books
Yalom, I. (2012) Love’s Executioner.New York, NY. Basic Books.
Yang, S., Sajatovic, M., & Walter, B. L. (2012) Psychosocial interventions for depression and anxiety in Parkinson’s disease. Journal of Geriatric Psychiatry and Neurology, 25, 2, 113–121
Downloads
Published
How to Cite
Issue
Section
License
Copyright lies with the journal. Enquiries regarding reproduction should be sent in the first place to enquiries@whitingbirch.net
